Why Is Revelation Biosciences (REVB) Stock Down 62% Today?


  • Revelation Biosciences (REVB) stock is down after pricing a public offering.
  • The company is selling 1.36 million shares and warrants for another 2.73 million shares for $4.53 each.
  • It expects gross proceeds of $6.2 million from the public offering.
REVB Stock - Why Is Revelation Biosciences (REVB) Stock Down 62% Today?

Source: Shutterstock

Revelation Biosciences (NASDAQ:REVB) stock is falling on Thursday after the life sciences company announced pricing for a public offering of its shares.

Revelation Biosciences is selling 1.36 million shares of REVB stock combined with warrants for another 2.73 million shares. The offering price for these units is $4.53 each. The warrants also have an exercise price that matches that and will expire five years after being issued.

Revelation Biosciences is expecting gross proceeds of $6.2 million from the public offering. The company notes that it intends to use these funds to further the development of several of its product candidates. Any left over after that will be used for working capital and general corporate purposes.

What This Means for REVB Stock

A public offering increases the total number of REVB shares on the public market. Doing so also dilutes the stakes of current shareholders in the company. That helps explain why REVB stock is falling on Thursday as investors react to the news.

Adding to that is the offering price of $4.53 per share. This is a massive discount over the prior closing price of $8.80 per share for REVB. It makes sense that this decreased offering price would pull down the value of Revelation Biosciences’ shares today.

REVB stock is down 61.6% as of Thursday morning.

Investors who want more of the most recent stock market stories are in luck!

We have all of the hottest news traders need to know about on Thursday! A few examples include what’s happening with Kiora Pharmaceuticals (NASDAQ:KPRX), Peloton Interactive (NASDAQ:PTON) and Elevai Labs (NASDAQ:ELAB) stock today. All of that info is available at the following links!

More Thursday Stock Market News

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks. 

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Article printed from InvestorPlace Media, https://investorplace.com/2024/02/why-is-revelation-biosciences-revb-stock-down-62-today/.

©2024 InvestorPlace Media, LLC